Stephens Inc. AR Invests $905,000 in Simulations Plus, Inc. (NASDAQ:SLP)

Stephens Inc. AR acquired a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 32,447 shares of the technology company’s stock, valued at approximately $905,000. Stephens Inc. AR owned 0.16% of Simulations Plus as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Barclays PLC boosted its holdings in shares of Simulations Plus by 390.6% during the third quarter. Barclays PLC now owns 28,473 shares of the technology company’s stock worth $911,000 after acquiring an additional 22,669 shares during the period. Geode Capital Management LLC raised its position in shares of Simulations Plus by 4.4% in the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock valued at $14,367,000 after buying an additional 18,924 shares in the last quarter. State Street Corp raised its position in shares of Simulations Plus by 4.7% in the third quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after buying an additional 28,953 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Simulations Plus by 106.0% in the third quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company’s stock valued at $1,517,000 after buying an additional 24,371 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its position in shares of Simulations Plus by 402.9% in the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock valued at $1,279,000 after buying an additional 32,002 shares in the last quarter. Institutional investors own 78.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on SLP. BTIG Research dropped their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. KeyCorp lifted their price target on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. Finally, Stephens started coverage on shares of Simulations Plus in a research report on Friday, November 15th. They set an “overweight” rating and a $39.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Simulations Plus has a consensus rating of “Moderate Buy” and an average target price of $49.40.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the sale, the director now owns 3,402,584 shares of the company’s stock, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 19.40% of the company’s stock.

Simulations Plus Price Performance

Shares of SLP opened at $37.01 on Friday. The firm has a 50 day simple moving average of $31.11 and a two-hundred day simple moving average of $32.32. The company has a market cap of $743.60 million, a P/E ratio of 92.53 and a beta of 0.83. Simulations Plus, Inc. has a one year low of $24.00 and a one year high of $51.22.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.